ClinicalTrials.govpublic full text
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
treatment efficacy, anti-pd-1 monoclonal antibodies, parp inhibitors, breast cancer, homologous recombination deficiency, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865882
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.